@noyalb @vstokes @Investopedia It's really the CC Pharma division that's helping them out the most (which accounted for 74% of their net revs last Q). Irwin Simon's ambition for the company is to become the largest medical Cannabis supplier in Europe & Latin America. Also their commitment to robotics processing (all totally controlled within an indoor environment) really cuts down on production costs.
  • 7